Active Pharmaceutical Ingredients
Product Name
CAS Number
Specification
DMF
CEP
Status
CN
PV
Tucatinib
937263-43-9
Q1 2027
Q3 2026
Zanubrutinib
1691249-45-2
Q2 2027
Q4 2026
Elexacaftor
2216712-66-0
Q1 2027
Q3 2026
Tezacaftor
1152311-62-0
Q1 2027
Q3 2026
Limaprost
74397-12-9
Q2 2027
Q4 2026
Treprostinil
81846-19-7
Q2 2027
Q4 2026
Atogepant
1374248-81-3
Q1 2027
Q3 2026
Rimegepant
1289023-67-1
Q2 2027
Q4 2026
Ubrogepant
1374248-77-7
Q3 2027
Q1 2027
Alogliptin benzoate
850649-62-6
Q1 2027
Q3 2026
Baxdrostat
1428652-17-8
Q2 2027
Q4 2026
Borofalan (10B)
80994-59-8
Q2 2027
Q4 2026
Camizestrant
2222844-89-3
Q2 2027
Q4 2026
Brensocatib
2923839-30-7
Q3 2027
Q1 2027
Clazosentan
180384-56-9
Q2 2027
Q4 2026
Elinzanetant
929046-33-3
Q4 2027
Q2 2027
Eprazinone Hydrochloride
10402-53-6
Q2 2027
Q4 2026
Esaxerenone
1632006-28-0
Q2 2027
Q4 2026
Fosravuconazole L-ysine Ethanolate
914361-45-8
Q3 2027
Q2 2027
Iptacopan
2447007-60-3
Q3 2027
Q1 2027